Dutch LATER study group 2022, ' Hypertension in long-term childhood cancer survivors after treatment with potentially nephrotoxic therapy; DCCSS-LATER 2 : Renal study ', European Journal of Cancer, vol. 172, pp. 287-299 . https://doi.org/10.1016/j.ejca.2022.05.038 European Journal of Cancer, 172, 287-299. ELSEVIER SCI LTD European Journal of Cancer, 172, 287-299. Elsevier Ltd. European Journal of Cancer, 172, pp. 287-299 European Journal of Cancer, 172, 287-299. Pergamon European Journal of Cancer, 172, 287-299. Elsevier Limited European Journal of Cancer, 172, 287-299
Cancer Reports, 6, 2 Beijer, J G M, Kok, J L, Janssens, G O, Streefkerk, N, de Vries, A C H, Slagter, C, Maduro, J H, Kroon, P S, Grootenhuis, M A, van Dulmen-den Broeder, E, Loonen, J J, Wendling, M, Tissing, W J E, van der Pal, H J, Louwerens, M, Bel, A, den Hartogh, J, van der Heiden-van der Loo, M, Kremer, L C M, Teepen, J C & Ronckers, C C M 2023, ' Adverse late health outcomes among children treated with 3D radiotherapy techniques : Study design of the Dutch pediatric 3D-RT study ', Cancer reports (Hoboken, N.J.), vol. 6, no. 2, e1620 . https://doi.org/10.1002/cnr2.1620 Cancer Reports, 6(2). WILEY Cancer Reports, 6 Cancer reports (Hoboken, N.J.), 6(2):e1620. Wiley-Blackwell Publishing Ltd
Pediatric Blood & Cancer, 70(5). WILEY Pediatric Blood and Cancer, 70(5):e30212. Wiley-Liss Inc. Pediatric Blood & Cancer, 70, 5 Pediatric Blood & Cancer, 70 Feijen, E A M, Teepen, J C, van Dulmen-den Broeder, E, van den Heuvel-Eibrink, M M, van der Heiden-van der Loo, M, van der Pal, H J H, de Vries, A C H, Louwerens, M, Bresters, D, Versluys, B, de Ridder, H, Veening, M, van Leeuwen, F E, Grootenhuis, M, Maurice-Stam, H, van Santen, H M, Neggers, S J C M M, Pluijm, S, den Hartogh, J, Ronckers, C C M, Tissing, W J E, Loonen, J J & Kremer, L C M 2023, ' Clinical evaluation of late outcomes in Dutch childhood cancer survivors : Methodology of the DCCSS LATER 2 study ', Pediatric Blood and Cancer, vol. 70, no. 5, e30212 . https://doi.org/10.1002/pbc.30212